HOME >> BIOLOGY >> NEWS
The greening of the North: real, and caused by climate change

Some years ago Ranga Myneni and his colleagues at Boston University published a paper in Nature apparently showing a "greening trend" in the boreal regions. The finding was based on satellite observations, and many scientists were sceptical about it because of problems of instrumental "drift" that could possibly make any observed long-term trend unreliable. The Boston team, however, persisted in their efforts to re-analyze the data, taking into account all possible anomalies. The trend would not go away, and it has become clearer with time as new data have come in.

A possible cause was always obvious: weather station records from the North have reported a steady warming (by about 0.4 degree per decade), which is now generally attributed to the increasing greenhouse effect. Warming in the North might be expected to produce "greening". However, it was not trivial to connect the weather station data to the satellite data to find out whether there was a quantitative correlation between the two trends. Although computer-based numerical models of the physical climate have been used for three decades to analyze the possible consequences of increasing greenhouse gas concentrations, comparable global models of ecosystem dynamics are a much more recent development.

Now, a major activity of the Global Ecology research group at MPI-BGC, under the leadership of Prof. Colin Prentice, is the ongoing development of a leading global terrestrial ecosystem model. The model is called LPJ, after the three research groups (led by Prof. Colin Prentice at MPI-BGC, Prof. Wolfgang Cramer at PIK; and Prof. Martin Sykes at Lund University) that participate in the model development consortium. The basic idea of the model is to integrate current knowledge in separate fields (plant physiology and biophysics, terrestrial ecology and hydrology), to simulate the interaction of processes with different time constants (minutes to years), and to use all possible sources of information
'"/>

Contact: I.Colin Prentice
colin.prentice@bgc-jena.mpg.de
49-3641-643-774
Max-Planck-Gesellschaft
10-Jun-2002


Page: 1 2 3 4

Related biology news :

1. Climate change plus human pressure caused large mammal extinctions in late Pleistocene
2. New evidence says Earths greatest extinction caused by ancient meteorite
3. Widespread cannibalism may have caused prehistoric prion disease epidemics, Science study suggests
4. Cell density determines extent of damage caused by cigarette smoke exposure
5. Prion disease may be caused by buildup of cellular trash, say Stanford researchers
6. Environmental enrichment reverses learning impairments caused by lead poisoning
7. The effects of human-caused atmospheric changes on tropical forests
8. Widespread amphibian deformities caused by parasite
9. River blindness caused by bacteria, not worms, suggesting antibiotic treatment for the disease, Science researchers say
10. Johns Hopkins researchers find more extensive bone defects caused by bladder exstrophy
11. Studies: Floyd, other major hurricanes of 99 caused significant changes in nations largest lagoonal estuary

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The greening the North real and caused climate change

(Date:5/10/2015)... , May 11, 2015 Fingerprint ... sensors FPC1025 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... will be used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK for ...
(Date:5/7/2015)... May 7, 2015 Fingerprint ... FPC1022 and FPC1035, FPC,s smallest touch fingerprint sensors ... mainly considered for integration on the backside of ... OEMs increased possibilities to integrate touch fingerprint sensors ... also improves possibilities for module manufacturers to customize ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
(Date:5/20/2015)... 20, 2015 Veracyte, Inc . ... demonstrating the ability of the company,s molecular classifier ... other interstitial lung diseases (ILDs) using samples obtained ... to help thousands of patients avoid invasive, risky ... diagnosis – a frequent challenge for physicians and ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/qfxkcq/global_cell ) has announced ... Outlook 2020 " report to their offering. ... medicine is expected to have huge marketing potential. Presently, ... the growth of deregulated organs. Several therapeutic molecules are ... form new tissue or sometimes organ transplant is required. ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
Cached News: